Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410714 | SCV000485383 | pathogenic | Niemann-Pick disease type C1 | 2016-09-09 | criteria provided, single submitter | clinical testing | |
Integrated Genetics/Laboratory Corporation of America | RCV000781671 | SCV000919894 | pathogenic | Niemann-Pick disease, type C | 2017-12-04 | criteria provided, single submitter | clinical testing | Variant summary: The NPC1 c.352_353delAG (p.Gln119ValfsX8) variant results in a premature termination codon, predicted to cause a truncated or absent NPC1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.1819C>T, p.Arg607X; c.3742_3745delCTCA, p.Leu1248fsX3). One in silico tool predicts a damaging outcome for this variant. This variant was found in 2/246198 control chromosomes at a frequency of 0.0000081, which does not exceed the estimated maximal expected allele frequency of a pathogenic NPC1 variant (0.0027735). The variant has been reported in affected individuals in the literature, and one functional study showed the variant results in reduced mRNA due to non-sense mediated decay (Marcias-Vidal_2009). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. |
Natera, |
RCV000410714 | SCV001459999 | pathogenic | Niemann-Pick disease type C1 | 2020-09-16 | no assertion criteria provided | clinical testing |